Riskpilot← Back to searchSign inGet full accessInsolidex AB
ABBankruptOrg 5590152061LundManufacture of medical and dental instruments and supplies · NACE 3250Est. 20151 employees
Revenue 2023
SEK -7K
-106% vs 2022
EBITDA margin
5086.9%
-104% vs 2022
Equity ratio
96.8%
Financial strength
Net profit 2023
SEK -340K
-104% vs 2022
| Revenue | SEK -7K | -106% |
| EBITDA | SEK -331K | -104% |
| Net profit | SEK -340K | -104% |
| Total assets | SEK 10,1M | -4% |
| Equity | SEK 9,8M | -3% |
| Employees | 1 | — |
Legal name
Insolidex AB
Org number
5590152061
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
27 maj 2015
Share capital
SEK 59 523
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva tillverkning av medicinsk utrustning samt därmed förenlig verksamhet.
Address
Lund
Email
ola.sellert@tragardh.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 84 | 507 | 175 | 128 | 118 | −7 |
| Staff expenses | — | — | — | — | — | — | — | −1 | −0 |
| EBITDA | −40 | −278 | −2 620 | −2 638 | −1 987 | −1 391 | −1 433 | 7 824 | −331 |
| Depreciation & amort. | −0 | −0 | −0 | −2 | −14 | −14 | −14 | −14 | −11 |
| EBIT | −40 | −278 | −2 620 | −2 640 | −2 001 | −1 405 | −1 447 | 7 810 | −342 |
| Net financials | — | −2 | — | — | −8 | −40 | −33 | −8 | 2 |
| Profit before tax | −40 | −279 | −2 620 | −2 640 | −2 009 | −1 445 | −1 480 | 7 802 | −340 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| Net profit | −40 | −279 | −2 620 | −2 640 | −2 009 | −1 445 | −1 480 | 7 802 | −340 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 130 | 1 436 | 1 645 | 1 686 | 1 088 | 776 | 505 | 10 522 | 10 125 |
| Equity | 120 | 1 408 | 838 | 946 | −817 | 66 | 61 | 10 143 | 9 803 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Short-term debt | 10 | 28 | 806 | 740 | 1 905 | 710 | 444 | 379 | 323 |
| Total debt | 10 | 28 | 806 | 740 | 1 905 | 710 | 444 | 379 | 323 |
EBITDA margin
-33090200.0%
This company
15.8%
Market median
-209431746% vs market
20152023
Equity ratio
96.8%
This company
38.2%
Market median
+153% vs market
20152023
Return on equity
-3.5%
This company
18.4%
Market median
-119% vs market
20152023
Net profit margin
-34029500.0%
This company
8.1%
Market median
-420117384% vs market
20152023
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20152023
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20152023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-05-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HE Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
DO Liquidator | Liquidator | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Insolidex AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| H E Makramalla | Chief Executive Officer | 0 companies |
| Dan Ola Magnus Sellert | Liquidator | 0 companies |
| Mohamad Nour Ali Ismail | Deputy Board Member | 0 companies |
| Ali Mohamad Ismail | Chairman | 0 companies |